Click Here for 5% Off Your First Aladdin Purchase!

Siponimod (BAF312) - 98%, high purity , Sphingosine 1-phosphate receptor Edg-1 agonist, CAS No.1230487-00-9, Sphingosine 1-phosphate receptor Edg-1 agonist

  • Moligand™
  • ≥98%
Item Number
S413720
Grouped product items
SKUSizeAvailabilityPrice Qty
S413720-2mg
2mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$31.90
S413720-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$64.90
S413720-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$97.90
S413720-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$282.90
S413720-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$391.90

S1P Receptor Agonists

Basic Description

SynonymsSiponimod|1230487-00-9|BAF312 (Siponimod)|BAF-312|NVP-BAF312-NX|BAF312|Siponimod [INN]|Mayzent|Siponimod [WHO-DD]|1230487-85-0|UNII-RR6P8L282I|Siponimod [USAN]|RR6P8L282I|BAF-312(SiponiMod)|CHEMBL2336071|BAF 312|DTXSID40153847|1-[[4-[(E)-N-[[4-cyclohexyl-
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsBAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits >1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase 3.
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionSphingosine 1-phosphate receptor Edg-1 agonist
Product Description

Information

Siponimod (BAF312) BAF312 (Siponimod) is a next-generation S1P receptor agonist, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits >1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase 3.


Targets

S1P1 receptor ; S1P5 receptor 0.39 nM(EC50); 0.98 nM(EC50)


In vitro

BAF312 (Siponimod) is a potent and selective S1P receptor agonist, with EC50 of 0.39 nM and 0.98 nM for S1P1 and S1P5receptors, exhibits >1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. BAF312 (1 h at 1 μM) promotes prominent internalization of S1P1 receptors by 91%.


In vivo

BAF312 effectively suppresses encephalomyelitis (EAE) in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes. BAF312 significantly reduces clinical scores when dosed prophylactically or therapeutically in mice at 0.3 mg/kg.


Cell Research(from reference)

Cell lines:CHO 

Concentrations:~1 μM 

Incubation Time:1 h 

Product Properties

ALogP3.834
Rotatable Bond10

Associated Targets

S1PR5 Tclin Sphingosine 1-phosphate receptor 5 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

S1PR4 Tclin Sphingosine 1-phosphate receptor 4 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

S1PR1 Tclin Sphingosine 1-phosphate receptor 1 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

S1PR3 Tclin Sphingosine 1-phosphate receptor 3 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid
INCHI InChI=1S/C29H35F3N2O3/c1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32/h9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36)/b33-19+
InChi Key KIHYPELVXPAIDH-HNSNBQBZSA-N
Canonical SMILES CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O
Isomeric SMILES CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O
PubChem CID 44599207
Molecular Weight 516.6

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
G2228168Certificate of AnalysisMay 31, 2022 S413720
G2228171Certificate of AnalysisMay 31, 2022 S413720
G2228172Certificate of AnalysisMay 31, 2022 S413720

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro DMSO: 100 mg/mL warmed with 50ºC Water: bath (193.57 mM); Ethanol: 44 mg/mL warmed with 50ºC Water: bath (85.17 mM); Water: Insoluble;
SensitivityHygroscopic
DMSO(mg / mL) Max Solubility100
DMSO(mM) Max Solubility193.5733643
Water(mg / mL) Max Solubility<1
Melt Point(°C)154 - 157°C

Related Documents

References

1. Gergely P, Nuesslein-Hildesheim B, Guerini D, Brinkmann V, Traebert M, Bruns C, Pan S, Gray NS, Hinterding K, Cooke NG et al..  (2012)  The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate..  Br J Pharmacol,  167  (5): (1035-47).  [PMID:22646698]
2. Lewis ND, Haxhinasto SA, Anderson SM, Stefanopoulos DE, Fogal SE, Adusumalli P, Desai SN, Patnaude LA, Lukas SM, Ryan KR et al..  (2013)  Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3..  J Immunol,  190  (7): (3533-40).  [PMID:23436932]
3. O'Sullivan C, Schubart A, Mir AK, Dev KK.  (2016)  The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures..  J Neuroinflammation,  13  (3): (31).  [PMID:26856814]
4. Pan S, Gray NS, Gao W, Mi Y, Fan Y, Wang X, Tuntland T, Che J, Lefebvre S, Chen Y et al..  (2013)  Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator..  ACS Med Chem Lett,  (3): (333-7).  [PMID:24900670]
5. Subei AM, Cohen JA.  (2015)  Sphingosine 1-phosphate receptor modulators in multiple sclerosis..  CNS Drugs,  29  (7): (565-75).  [PMID:26239599]
6. Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L et al..  (2016)  Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis..  J Neuroinflammation,  13  (1): (207).  [PMID:27566665]
7. Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T et al..  (2018)  Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study..  Lancet,  391  (10127): (1263-1273).  [PMID:29576505]

Solution Calculators